Newer therapeutic approaches towards the management of diabetes mellitus: an update.


Journal

Panminerva medica
ISSN: 1827-1898
Titre abrégé: Panminerva Med
Pays: Italy
ID NLM: 0421110

Informations de publication

Date de publication:
Sep 2023
Historique:
medline: 23 10 2023
pubmed: 31 10 2019
entrez: 31 10 2019
Statut: ppublish

Résumé

Diabetes mellitus is a chronic metabolic condition characterized by an elevation of blood glucose levels, resulting from defects in insulin secretion, insulin action, or both. The prevalence of the disease has been rapidly rising all over the globe at an alarming rate. Despite advances in the management of diabetes mellitus, it remains a growing epidemic that has become a significant public health burden due to its high healthcare costs and its complications. There is no cure has yet been found for the disease, however, treatment modalities include insulin and antidiabetic agents along with lifestyle modifications are still the mainstay of therapy for diabetes mellitus. The treatment spectrum for the management of diabetes mellitus has rapidly developed in recent years, with new class of therapeutics and expanded indications. This article focused on the emerging therapeutic approaches other than the conventional pharmacological therapies, which include stem cell therapy, gene therapy, siRNA, nanotechnology and theranostics.

Identifiants

pubmed: 31663302
pii: S0031-0808.19.03655-3
doi: 10.23736/S0031-0808.19.03655-3
doi:

Substances chimiques

Hypoglycemic Agents 0
Insulin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

362-375

Auteurs

Heng L Lin (HL)

School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia.

Fathin N Mohamed Shukri (FN)

School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia.

Eric S Yih (ES)

School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia.

Grace H Sha (GH)

School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia.

Grace S Jing (GS)

School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia.

Gan W Jin (GW)

School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia.

Chow W Hoong (CW)

School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia.

Choong Q Ying (CQ)

School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia.

Bibhu P Panda (BP)

Department of Pharmaceutical Technology, School of Pharmacy, Taylor's University, Lakeside Campus, Subang Jaya, Selangor, Malaysia.

Mayuren Candasamy (M)

Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia.

Subrat K Bhattamisra (SK)

Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia - subratkumar@imu.edu.my.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH